aigatherapeutics.com
Innovation Type:
Therapeutics
Cancer Type:
Multiple
Funding Stage:
pre-seed
Fund:
Prospects
Proprietary alpha-particle radioligand based platform using precision targeting to deliver unparalleled lethal radiation directly to cancer cells.